Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (NNFN) vs. Competitors

10 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NNFNMannKindEUR 3.49EUR 1.13B-16.35-19.97%Strong BuyUnlock the DE:NNFN analyst price target with TipRanks PremiumDE:NNFNUnlock the DE:NNFN top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.53$681.21M-10.5315.91%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumDE:NNFN vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.41$1.31B7.25-13.00%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumDE:NNFN vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.26$939.86M-6.98-8.78%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumDE:NNFN vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.97$3.10B-423.19148.10%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumDE:NNFN vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NNFNMannKind3.49-0.84-19.43%
LXRXLexicon Pharmaceuticals1.530.117.75%
INVAInnoviva18.41-2.88-13.53%
SVRASavara4.26-0.95-18.23%
XERSXeris Pharmaceuticals16.979.93141.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts